Literature DB >> 29075594

Irreversible electroporation of stage 3 locally advanced pancreatic cancer: optimal technique and outcomes.

Robert C G Martin1.   

Abstract

OBJECTIVE: Irreversible electroporation (IRE) of stage 3 pancreatic adenocarcinoma has been used to provide quality of life time in patients who have undergone appropriate induction therapy. The optimal technique has been reported within the literature, but not in video form. IRE of locally advanced pancreatic cancer is technically demanding requiring precision ultrasound use for continuous imaging in multiple needle placements and during IRE energy delivery.
METHODS: Appropriate patients with locally advanced pancreatic cancer should have undergone appropriate induction chemotherapy for a reasonable duration. The safe and effective technique for irreversible electroporation is preformed through an open approach with the emphasis on intra-operative ultrasound and intra-operative electroporation management.
RESULTS: The technique of open irreversible electroporation of the pancreas involves bracketing the target tumor with IRE probes and any and all invaded vital structures including the celiac axis, superior mesenteric artery (SMA), superior mesenteric-portal vein, and bile duct with continuous intraoperative ultrasound imaging through a caudal to cranial approach. Optimal IRE delivery requires a change in amperage of at least 12 amps from baseline tissue conductivity in order to achieve technical success. Multiple pull-backs are necessary since the IRE ablation probe lengths are 1 cm and thus needed to achieve technical success along the caudal to cranial plane.
CONCLUSIONS: Irreversible electroporation in combination with multi-modality therapy for locally advanced pancreatic carcinoma is feasible for appropriate patients with locally advanced cancer. Technical demands are high and require the highest quality ultrasound for precise spacing measurements and optimal delivery to ensure adequate change in tissue resistance.

Entities:  

Keywords:  Pancreatic cancer; irreversible electroporation (IRE); locally advanced; stage 3 pancreatic; technique

Year:  2015        PMID: 29075594      PMCID: PMC5638541          DOI: 10.3978/j.issn.2221-2965.2015.05.02

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  16 in total

1.  Electrical impedance tomography for imaging tissue electroporation.

Authors:  Rafael V Davalos; David M Otten; Lluis M Mir; Boris Rubinsky
Journal:  IEEE Trans Biomed Eng       Date:  2004-05       Impact factor: 4.538

2.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

3.  In vivo results of a new focal tissue ablation technique: irreversible electroporation.

Authors:  Jon F Edd; Liana Horowitz; Rafael V Davalos; Lluis M Mir; Boris Rubinsky
Journal:  IEEE Trans Biomed Eng       Date:  2006-07       Impact factor: 4.538

4.  Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

Authors:  Mark P Callery; Kenneth J Chang; Elliot K Fishman; Mark S Talamonti; L William Traverso; David C Linehan
Journal:  Ann Surg Oncol       Date:  2009-04-24       Impact factor: 5.344

5.  Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.

Authors:  Matthew Bower; Leslie Sherwood; Yan Li; Robert Martin
Journal:  J Surg Oncol       Date:  2011-02-28       Impact factor: 3.454

6.  Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.

Authors:  David Kwon; Kelli McFarland; Vic Velanovich; Robert C G Martin
Journal:  Surgery       Date:  2014-10       Impact factor: 3.982

7.  Irreversible electroporation of locally advanced pancreatic head adenocarcinoma.

Authors:  Robert C G Martin
Journal:  J Gastrointest Surg       Date:  2013-08-09       Impact factor: 3.452

8.  The anatomic location of pancreatic cancer is a prognostic factor for survival.

Authors:  Avo Artinyan; Perry A Soriano; Christina Prendergast; Tracey Low; Joshua D I Ellenhorn; Joseph Kim
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  Ann Surg Oncol       Date:  2012-11-06       Impact factor: 5.344

10.  Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.

Authors:  Karl Y Bilimoria; David J Bentrem; Ryan P Merkow; James S Tomlinson; Andrew K Stewart; Clifford Y Ko; Mark S Talamonti
Journal:  J Am Coll Surg       Date:  2007-08-03       Impact factor: 6.113

View more
  3 in total

1.  Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.

Authors:  Travis E Grotz; Jennifer A Yonkus; Cornelius A Thiels; Susanne G Warner; Robert R McWilliams; Amit Mahipal; Tanios S Bekaii-Saab; Sean P Cleary; Michael L Kendrick; Mark J Truty
Journal:  Ann Surg Oncol       Date:  2022-08-16       Impact factor: 4.339

Review 2.  The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer.

Authors:  Argyrios Gyftopoulos; Ioannis A Ziogas; Andrew S Barbas; Dimitrios Moris
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

3.  Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.

Authors:  Pierre Agnass; Eran van Veldhuisen; Jantien A Vogel; H Petra Kok; Mark J de Keijzer; Gerben Schooneveldt; Lianne R de Haan; John H Klaessens; Hester J Scheffer; Martijn R Meijerink; Krijn P van Lienden; Thomas M van Gulik; Michal Heger; Johannes Crezee; Marc G Besselink
Journal:  J Clin Transl Res       Date:  2020-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.